Skip to Content

Green Cures & Botanical Distribution Inc GRCU

Morningstar Rating
$0.00 0.00 (37.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GRCU is trading at a 678% premium.
Price
$0.00
Fair Value
$1.67
Uncertainty
Extreme
1-Star Price
$6.19
5-Star Price
$7.78
Economic Moat
Qpgt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GRCU is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$609,342.01
Volume/Avg
1.0 Mil / 21.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Green Cures & Botanical Distribution Inc is engaged in the healthcare sector. It retails and wholesales hemp infused nutritional, medicinal and body care products in the hemp and botanical industry, including nutritional supplements and sports wellness. Its brands include Original Hollywood Hemp, Green Foods, and Green Cures Spirits which are sold through its e-commerce sites, originalhollywoodhemp.com, and other third-party e-commerce sites.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
34

Valuation

Metric
GRCU
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
GRCU
Quick Ratio
0.00
Current Ratio
0.09
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
GRCU
Return on Assets (Normalized)
−575.89%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
BpbkcslxklFzh$81.5 Bil
Merck KGaA ADR
MKKGY
ZqcvsclpsFprzkk$80.4 Bil
Haleon PLC ADR
HLN
BjlmmyvDpmg$37.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
ZfcrkbzvsNhkd$19.1 Bil
Viatris Inc
VTRS
GzywyrnbqLcbcy$12.7 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
JcdllmmlVqrm$12.0 Bil
Catalent Inc
CTLT
DczbpdtgKyyzfh$10.1 Bil
Perrigo Co PLC
PRGO
PsdwjpsqBhy$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
XlngnxmDvfjrx$3.3 Bil
Curaleaf Holdings Inc
CURLF
FcrlfykcVkdq$3.2 Bil

Sponsor Center